https://www.rnaiscience.com/ 2026-03-26T00:40:14-04:00 daily 1.0 https://www.rnaiscience.com/alnylam-rnai 2026-01-09T00:51:35-05:00 0.5 https://www.rnaiscience.com/search 2026-03-26T06:41:13-04:00 0.5 https://www.rnaiscience.com/connect-with-us 2025-06-03T06:13:32-04:00 0.5 https://www.rnaiscience.com/therapeutic-areas 2025-06-02T04:08:20-04:00 0.5 https://www.rnaiscience.com/our-therapies 2026-03-26T06:44:35-04:00 0.5 https://www.rnaiscience.com/pipeline-clinical-trials 2025-06-03T05:54:22-04:00 0.5 https://www.rnaiscience.com/congresses-publications 2026-03-26T04:20:51-04:00 0.5 https://www.rnaiscience.com/therapeutic-areas/transthyretin-amyloidosis 2026-03-26T06:27:57-04:00 0.5 https://www.rnaiscience.com/pipeline-clinical-trials/pipeline 2026-03-30T04:25:18-04:00 0.5 https://www.rnaiscience.com/our-therapies/patisiran 2026-03-26T06:34:23-04:00 0.5 https://www.rnaiscience.com/our-therapies/vutrisiran 2026-03-26T06:36:12-04:00 0.5 https://www.rnaiscience.com/therapeutic-areas/cardiovascular-CV 2026-03-26T06:28:28-04:00 0.5 https://www.rnaiscience.com/pipeline-clinical-trials/pipeline/zilebesiran 2026-03-30T09:37:03-04:00 0.5 https://www.rnaiscience.com/congresses-publications/american-college-cardiology-2024-ttr 2025-03-18T12:03:32-04:00 0.5 https://www.rnaiscience.com/congresses-publications/european-society-hypertension-2024 2025-03-18T12:06:41-04:00 0.5 https://www.rnaiscience.com/congresses-publications/international-society-amyloidosis-2024 2025-03-18T12:02:25-04:00 0.5 https://www.rnaiscience.com/congresses-publications/american-college-cardiology-2024-htn 2025-03-18T12:07:18-04:00 0.5 https://www.rnaiscience.com/congresses-publications/peripheral-nerve-society-pns-2024 2025-03-04T06:25:38-05:00 0.5 https://www.rnaiscience.com/therapeutic-areas/acute-hepatic-porphyria-ahp 2026-03-26T06:27:17-04:00 0.5 https://www.rnaiscience.com/therapeutic-areas/primary-hyperoxaluria-type-1-ph1 2026-03-26T06:28:38-04:00 0.5 https://www.rnaiscience.com/our-therapies/givosiran 2026-03-26T06:31:31-04:00 0.5 https://www.rnaiscience.com/our-therapies/lumasiran 2026-03-26T06:32:50-04:00 0.5 https://www.rnaiscience.com/congresses-publications/european-renal-association-era-2024 2025-03-04T06:22:44-05:00 0.5 https://www.rnaiscience.com/congresses-publications/american-society-pediatric-nephrology-aspn-pediatric-academic-societies-pas-2024 2025-03-18T12:12:29-04:00 0.5 https://www.rnaiscience.com/congresses-publications/national-kidney-foundation-nkf-2024 2025-03-04T06:23:23-05:00 0.5 https://www.rnaiscience.com/congresses-publications/european-association-study-liver-easl-2024 2025-03-04T04:46:52-05:00 0.5 https://www.rnaiscience.com/congresses-publications/european-society-cardiology-2024 2025-03-04T06:24:47-05:00 0.5 https://www.rnaiscience.com/congresses-publications/european-society-cardiology-2024-htn 2025-03-04T06:24:22-05:00 0.5 https://www.rnaiscience.com/attrv-amyloidosis-hub 2024-08-21T13:41:39-04:00 0.5 https://www.rnaiscience.com/congresses-publications/international-congress-porphyrins-porphyrias-2024 2025-03-04T04:46:04-05:00 0.5 https://www.rnaiscience.com/congresses-publications/heart-failure-society-america-2024 2025-03-04T06:25:17-05:00 0.5 https://www.rnaiscience.com/congresses-publications/international-congress-porphyrins-porphyrias-2024/ENVISIONinfographic 2024-09-27T01:33:16-04:00 0.5 https://www.rnaiscience.com/congresses-publications/american-association-neuromuscular-electrodiagnostic-medicine-2024 2025-03-18T12:15:09-04:00 0.5 https://www.rnaiscience.com/payer-connect 2026-03-26T00:52:44-04:00 0.5 https://www.rnaiscience.com/congresses-publications/ph1-american-society-nephrology-asn-2024 2025-03-04T06:26:03-05:00 0.5 https://www.rnaiscience.com/congresses-publications/clinical-trials-on-alzheimers-disease-2024 2025-03-04T06:27:16-05:00 0.5 https://www.rnaiscience.com/congresses-publications/american-heart-association-2024 2025-03-04T03:28:36-05:00 0.5 https://www.rnaiscience.com/congresses-publications/ISPOR-EU-2024 2025-05-22T06:11:14-04:00 0.5 https://www.rnaiscience.com/congresses-publications/american-heart-association-2024-cv 2025-05-22T06:11:48-04:00 0.5 https://www.rnaiscience.com/congresses-publications/american-association-study-liver-diseases-aasld-2024 2025-05-22T06:14:01-04:00 0.5 https://www.rnaiscience.com/congresses-publications/sfnp-2025 2025-11-07T00:32:50-05:00 0.5 https://www.rnaiscience.com/congresses-publications/international-stroke-conference-2025 2025-11-07T00:33:12-05:00 0.5 https://www.rnaiscience.com/congresses-publications/ph1-pediatric-nephrology-association-2025 2025-11-07T00:33:33-05:00 0.5 https://www.rnaiscience.com/congresses-publications/american-college-cardiology-2025 2025-11-07T00:33:59-05:00 0.5 https://www.rnaiscience.com/congresses-publications/national-kidney-foundation-nkf-2025 2025-11-07T00:34:33-05:00 0.5 https://www.rnaiscience.com/congresses-publications/ph1-pediatric-academic-societies-2025 2025-11-07T00:34:57-05:00 0.5 https://www.rnaiscience.com/congresses-publications/ph1-american-urological-association-2025 2025-11-07T00:54:48-05:00 0.5 https://www.rnaiscience.com/congresses-publications/digestive-disease-week-2025 2025-11-07T00:54:57-05:00 0.5 https://www.rnaiscience.com/congresses-publications/ph1-european-renal-association-era-2025 2025-11-07T00:55:29-05:00 0.5 https://www.rnaiscience.com/congresses-publications/international-society-for-pharmacoeconomics-and-outcomes-research-2025 2025-11-07T00:55:39-05:00 0.5 https://www.rnaiscience.com/congresses-publications/peripheral-nerve-society-pns-2025 2025-11-07T00:55:47-05:00 0.5 https://www.rnaiscience.com/congresses-publications/heart-failure-association-2025 2025-11-07T00:56:30-05:00 0.5 https://www.rnaiscience.com/congresses-publications/alzheimers-association-international-conference-2025 2025-11-07T00:56:38-05:00 0.5 https://www.rnaiscience.com/therapeutic-areas/primary-hyperoxaluria-type-1-ph1/ph1casestudy 2025-11-06T12:19:51-05:00 0.5 https://www.rnaiscience.com/congresses-publications/ph1-international-pediatric-transplant-association-IPTA-2025 2025-11-07T00:57:57-05:00 0.5 https://www.rnaiscience.com/congresses-publications/international-congress-inborn-errors-metabolism-ICIEM-2025 2025-11-07T00:58:16-05:00 0.5 https://www.rnaiscience.com/congresses-publications/european-society-cardiology-2025-cv 2025-11-07T00:58:25-05:00 0.5 https://www.rnaiscience.com/congresses-publications/european-society-cardiology-2025 2025-11-07T00:58:34-05:00 0.5 https://www.rnaiscience.com/congresses-publications/european-society-paediatric-urology-ESPU-2025 2025-11-07T00:59:45-05:00 0.5 https://www.rnaiscience.com/congresses-publications/canadian-association-for-population-therapeutics-2025 2025-11-07T00:59:52-05:00 0.5 https://www.rnaiscience.com/congresses-publications/european-attr-amyloidosis-meeting-2025 2025-11-07T01:00:07-05:00 0.5 https://www.rnaiscience.com/congresses-publications/heart-failure-society-america-2025 2025-11-07T01:01:02-05:00 0.5 https://www.rnaiscience.com/congresses-publications/international-porphyrias-symposium-IPS-2025 2025-11-10T00:41:48-05:00 0.5 https://www.rnaiscience.com/congresses-publications/european-society-paediatric-nephrology-ESPN-2025 2025-11-07T01:01:57-05:00 0.5 https://www.rnaiscience.com/congresses-publications/american-heart-association-2025 2025-11-10T00:51:00-05:00 0.5 https://www.rnaiscience.com/congresses-publications/american-society-nephrology-ASN-2025 2025-11-10T00:49:57-05:00 0.5 https://www.rnaiscience.com/congresses-publications/american-association-study-liver-diseases-AASLD-2025 2025-11-10T00:40:54-05:00 0.5 https://www.rnaiscience.com/congresses-publications/ispor-eu-2025 2025-11-10T00:55:15-05:00 0.5 https://www.rnaiscience.com/congresses-publications/american-heart-association-2025-cv 2025-11-08T10:23:21-05:00 0.5 https://www.rnaiscience.com/congresses-publications/clinical-trials-alzheimers-disease-CTAD-2025 2025-12-12T01:47:44-05:00 0.5 https://www.rnaiscience.com/congresses-publications/global-cardiovascular-clinical-trialists-forum-CVCT-2025 2025-12-12T01:54:44-05:00 0.5 https://www.rnaiscience.com/congresses-publications/international-stroke-conference-ISC-2026 2026-02-09T23:31:53-05:00 0.5 https://www.rnaiscience.com/congresses-publications/thrombosis-hemostasis-summit-north-america-THSNA-2026 2026-03-30T09:42:48-04:00 0.5 https://www.rnaiscience.com/attr-cm-discovery-initiative 2026-03-24T11:44:39-04:00 0.7 https://www.rnaiscience.com/recognizing-both-chronic-and-acute-symptoms-acute-hepatic-porphyria 2026-03-24T11:44:39-04:00 0.7 https://www.rnaiscience.com/vutrisiran-cardiac-magnetic-resonance-imaging 2026-03-24T11:44:39-04:00 0.7 https://www.rnaiscience.com/vutrisiran-impact-thyroid-function 2026-03-24T11:44:39-04:00 0.7 https://www.rnaiscience.com/vutrisiran-post-hoc-analysis-helios-b-monotherapy-population-observations-following-tafamidis 2026-03-24T11:44:39-04:00 0.7 https://www.rnaiscience.com/vutrisiran-al-amyloidosis-or-leptomeningeal-amyloidosis 2026-03-24T11:44:39-04:00 0.7 https://www.rnaiscience.com/vutrisiran-gastrointestinal-events-helios-b 2026-03-24T11:44:39-04:00 0.7 https://www.rnaiscience.com/amyloidosis-project-echo 2026-03-24T11:44:39-04:00 0.7 https://www.rnaiscience.com/zilebesiran-zenith-study 2026-03-24T11:44:39-04:00 0.7 https://www.rnaiscience.com/vutrisiran-surgical-procedures 2026-03-24T11:44:39-04:00 0.7 https://www.rnaiscience.com/vutrisiran-use-mrna-covid-19-vaccines 2026-03-24T11:44:39-04:00 0.7 https://www.rnaiscience.com/vutrisiran-helios-b-ole 2026-03-24T11:44:39-04:00 0.7 https://www.rnaiscience.com/explore-attr-cm-0 2026-03-24T11:44:39-04:00 0.7 https://www.rnaiscience.com/alnylams-pipeline 2026-03-24T11:44:39-04:00 0.7 https://www.rnaiscience.com/diagnosing-ahp 2026-03-24T11:44:39-04:00 0.7 https://www.rnaiscience.com/rnai-data-navigator-focus-vutrisiran 2026-03-24T11:44:39-04:00 0.7 https://www.rnaiscience.com/vutrisiran-results-patients-who-had-progressed-tafamidis-helios-b 2026-03-24T11:44:39-04:00 0.7 https://www.rnaiscience.com/vutrisiran-helios-b-results-baseline-heart-failure-disease-severity 2026-03-24T11:44:39-04:00 0.7 https://www.rnaiscience.com/summary-rna-interference 2026-03-24T11:44:39-04:00 0.7 https://www.rnaiscience.com/vutrisiran-left-ventricular-ejection-fraction-helios-b 2026-03-24T11:44:39-04:00 0.7 https://www.rnaiscience.com/patisiran-autonomic-outcomes 2026-03-24T11:44:39-04:00 0.7 https://www.rnaiscience.com/aln-htt02-phase-1b-study 2026-03-24T11:44:39-04:00 0.7 https://www.rnaiscience.com/nucresiran-phase-1-study 2026-03-24T11:44:39-04:00 0.7 https://www.rnaiscience.com/vutrisiran-warming-administration 2026-03-31T18:33:00-04:00 0.7 https://www.rnaiscience.com/helios-b-plain-language-summary 2026-03-24T11:44:39-04:00 0.7 https://www.rnaiscience.com/attr-cm-helios-b-data-summary 2026-03-24T11:44:39-04:00 0.7 https://www.rnaiscience.com/vutrisiran-safety-results-helios-b 2026-03-25T02:02:24-04:00 0.7 https://www.rnaiscience.com/mivelsiran-cappricorn-1-study 2026-03-27T12:52:40-04:00 0.7 https://www.rnaiscience.com/understanding-ahp-infographic 2026-03-24T11:44:39-04:00 0.7 https://www.rnaiscience.com/long-term-assessment-patients-ahp-and-aip-who-were-not-attack-free-after-6-months-givosiran 2026-03-24T11:44:39-04:00 0.7 https://www.rnaiscience.com/bonaph1de-prospective-observational-study-patients-ph1 2026-03-24T11:44:39-04:00 0.7 https://www.rnaiscience.com/vutrisiran-cardiac-biomarkers-helios-b 2026-03-24T11:44:39-04:00 0.7 https://www.rnaiscience.com/vutrisiran-echocardiographic-assessments-helios-b 2026-03-24T11:44:39-04:00 0.7 https://www.rnaiscience.com/aspire-amyloidosis-industry-collaborative 2026-03-24T11:50:40-04:00 0.7 https://www.rnaiscience.com/lumasiran-clinical-program-overview 2026-03-24T11:50:40-04:00 0.7 https://www.rnaiscience.com/vutrisiran-concomitant-use-diflunisal 2026-03-24T11:50:40-04:00 0.7 https://www.rnaiscience.com/identifying-ahp-module 2026-03-24T11:50:40-04:00 0.7 https://www.rnaiscience.com/diagnosing-ph1-infographic 2026-03-24T11:50:40-04:00 0.7 https://www.rnaiscience.com/science-rna-interference-rnai 2026-03-24T11:50:40-04:00 0.7 https://www.rnaiscience.com/diagnosing-ahp-infographic 2026-03-24T11:50:40-04:00 0.7 https://www.rnaiscience.com/carpal-tunnel-release-surgery-handout 2026-03-24T11:50:40-04:00 0.7 https://www.rnaiscience.com/zilebesiran-kardia-1-study 2026-03-24T11:50:40-04:00 0.7 https://www.rnaiscience.com/phase-3-helios-b-study-rationale 2026-03-24T11:50:40-04:00 0.7 https://www.rnaiscience.com/givosiran-use-pediatric-patients 2026-03-24T11:50:40-04:00 0.7 https://www.rnaiscience.com/givosiran-hemin-use 2026-04-02T12:08:01-04:00 0.7 https://www.rnaiscience.com/givosiran-use-patients-pre-existing-renal-impairment 2026-03-24T11:50:40-04:00 0.7 https://www.rnaiscience.com/givosiran-pancreatitis 2026-03-24T11:50:40-04:00 0.7 https://www.rnaiscience.com/insights-helios-study 2026-03-24T11:50:40-04:00 0.7 https://www.rnaiscience.com/zilebesiran-kardia-2-study 2026-03-25T02:02:24-04:00 0.7 https://www.rnaiscience.com/zilebesiran-kardia-3-study 2026-03-24T11:50:40-04:00 0.7 https://www.rnaiscience.com/lumasiran-pediatric-weight-based-dosing-increase-regimen 2026-03-24T11:50:40-04:00 0.7 https://www.rnaiscience.com/vutrisiran-hypersensitivity-reactions 2026-03-24T11:50:40-04:00 0.7 https://www.rnaiscience.com/potential-predictors-ph1-pediatric-patients 2026-03-24T11:50:40-04:00 0.7 https://www.rnaiscience.com/vutrisiran-ocular-adverse-events 2026-03-24T11:50:40-04:00 0.7 https://www.rnaiscience.com/attr-screening-and-carrier-management 2026-03-24T11:50:40-04:00 0.7 https://www.rnaiscience.com/attr-symptoms-and-manifestations-early-indicators 2026-03-24T11:50:40-04:00 0.7 https://www.rnaiscience.com/helios-b-phase-3-study-design 2026-03-24T11:50:40-04:00 0.7 https://www.rnaiscience.com/givosiran-use-patients-without-identified-porphyria-related-mutation 2026-03-24T11:50:40-04:00 0.7 https://www.rnaiscience.com/attr-diagnostic-and-staging-tools 2026-03-24T11:50:40-04:00 0.7 https://www.rnaiscience.com/attr-management-guidelines 2026-03-24T11:50:40-04:00 0.7 https://www.rnaiscience.com/attr-disease-management 2026-03-24T11:50:40-04:00 0.7 https://www.rnaiscience.com/diagnosis-attr 2026-03-24T11:50:40-04:00 0.7 https://www.rnaiscience.com/screening-recognition-and-barriers-diagnosis-attr 2026-03-24T11:50:40-04:00 0.7 https://www.rnaiscience.com/symptoms-and-disease-burden-attr 2026-03-24T11:50:40-04:00 0.7 https://www.rnaiscience.com/understanding-attr-amyloidosis 2026-03-24T11:50:40-04:00 0.7 https://www.rnaiscience.com/hereditary-transthyretin-amyloidosis-polyneuropathy-united-states 2026-03-24T11:50:40-04:00 0.7 https://www.rnaiscience.com/attr-amyloidosis-disease-state-handout 2026-03-24T11:50:40-04:00 0.7 https://www.rnaiscience.com/givosiran-use-patients-pre-existing-hepatic-impairment 2026-03-24T11:50:40-04:00 0.7 https://www.rnaiscience.com/vutrisiran-use-patients-undergoing-dialysis 2026-03-30T18:16:00-04:00 0.7 https://www.rnaiscience.com/patisiran-serum-transthyretin-levels 2026-03-24T11:50:40-04:00 0.7 https://www.rnaiscience.com/vutrisiran-changes-serum-ttr-levels 2026-03-24T11:50:40-04:00 0.7 https://www.rnaiscience.com/vutrisiran-immunogenicity 2026-03-30T16:14:01-04:00 0.7 https://www.rnaiscience.com/hereditary-attr-amyloidosis-closer-look-v1221-variant 2026-03-24T11:50:40-04:00 0.7 https://www.rnaiscience.com/lumasiran-injection-site-reactions 2026-03-24T11:50:40-04:00 0.7 https://www.rnaiscience.com/mivelsiran-phase-1-study 2026-03-24T11:50:40-04:00 0.7 https://www.rnaiscience.com/patisiran-orthostatic-hypotension 2026-03-24T11:50:40-04:00 0.7 https://www.rnaiscience.com/vutrisiran-analysis-quality-life-and-physical-function-outcomes-helios 2026-03-24T12:18:01-04:00 0.7 https://www.rnaiscience.com/vutrisiran-orthostatic-hypotension 2026-03-24T12:18:01-04:00 0.7 https://www.rnaiscience.com/lumasiran-dosing-administration-window 2026-03-26T18:44:44-04:00 0.7 https://www.rnaiscience.com/vutrisiran-renal-related-adverse-events 2026-03-24T12:18:01-04:00 0.7 https://www.rnaiscience.com/lumasiran-clinical-pharmacology 2026-03-24T12:18:01-04:00 0.7 https://www.rnaiscience.com/transition-between-patisiran-and-vutrisiran 2026-03-24T12:18:01-04:00 0.7 https://www.rnaiscience.com/zilebesiran-phase-1-study-overview 2026-03-24T12:18:01-04:00 0.7 https://www.rnaiscience.com/zilebesiran-phase-2-studies 2026-03-24T12:18:01-04:00 0.7 https://www.rnaiscience.com/vutrisiran-technetium-scintigraphy 2026-03-24T12:18:01-04:00 0.7 https://www.rnaiscience.com/patisiran-dosing-schedule 2026-03-24T12:18:01-04:00 0.7 https://www.rnaiscience.com/vutrisiran-post-hoc-analysis-helios-results-baseline-nis-quartile 2026-03-24T13:02:15-04:00 0.7 https://www.rnaiscience.com/patisiran-apollo-b-ole-study 2026-03-26T12:52:34-04:00 0.7 https://www.rnaiscience.com/lumasiran-dialysis 2026-03-24T13:02:15-04:00 0.7 https://www.rnaiscience.com/lumasiran-kidney-related-outcomes 2026-03-24T13:02:15-04:00 0.7 https://www.rnaiscience.com/vutrisiran-autonomic-symptom-assessment 2026-03-24T13:02:15-04:00 0.7 https://www.rnaiscience.com/vutrisiran-survival-and-mortality 2026-03-24T13:02:15-04:00 0.7 https://www.rnaiscience.com/nfl-biomarker-hattr-amyloidosis-infographic 2026-03-24T13:02:15-04:00 0.7 https://www.rnaiscience.com/patisiran-immunogenicity 2026-03-24T13:02:15-04:00 0.7 https://www.rnaiscience.com/vutrisiran-randomized-treatment-extension-period-helios-study 2026-04-02T14:51:03-04:00 0.7 https://www.rnaiscience.com/givosiran-elevations-blood-homocysteine 2026-03-24T13:02:15-04:00 0.7 https://www.rnaiscience.com/lumasiran-use-kidney-transplantation 2026-03-24T13:02:15-04:00 0.7 https://www.rnaiscience.com/musculoskeletal-manifestations-associated-attr-amyloidosis 2026-03-24T13:19:01-04:00 0.7 https://www.rnaiscience.com/diagnosis-ph1-ckd-or-dialysis-patients 2026-03-24T13:19:01-04:00 0.7 https://www.rnaiscience.com/unpredictable-progression-ph1 2026-03-24T13:19:01-04:00 0.7 https://www.rnaiscience.com/vutrisiran-pain-extremity 2026-03-24T13:19:01-04:00 0.7 https://www.rnaiscience.com/vutrisiran-post-dose-monitoring 2026-03-24T13:19:01-04:00 0.7 https://www.rnaiscience.com/vutrisiran-vaccines 2026-03-24T13:19:01-04:00 0.7 https://www.rnaiscience.com/vutrisiran-use-patients-hepatic-impairment 2026-03-24T13:19:01-04:00 0.7 https://www.rnaiscience.com/patisiran-observation-period-after-infusion 2026-03-24T13:19:01-04:00 0.7 https://www.rnaiscience.com/vutrisiran-dosage-administration-schedule-used-phase-3-studies 2026-03-24T13:19:01-04:00 0.7 https://www.rnaiscience.com/vutrisiran-use-patients-heart-transplant 2026-03-24T13:19:01-04:00 0.7 https://www.rnaiscience.com/vutrisiran-cross-reactivity-patisiran 2026-03-24T13:19:01-04:00 0.7 https://www.rnaiscience.com/patisiran-apollo-b-study 2026-03-24T13:19:01-04:00 0.7 https://www.rnaiscience.com/vutrisiran-use-patients-renal-impairment 2026-03-24T13:19:01-04:00 0.7 https://www.rnaiscience.com/vutrisiran-arthralgia 2026-04-02T16:52:51-04:00 0.7 https://www.rnaiscience.com/vutrisiran-dyspnea 2026-03-25T02:02:24-04:00 0.7 https://www.rnaiscience.com/patisiran-management-infusion-related-reactions 2026-03-25T02:02:24-04:00 0.7 https://www.rnaiscience.com/vutrisiran-concomitant-use-tafamidis 2026-03-25T02:02:24-04:00 0.7 https://www.rnaiscience.com/vutrisiran-blood-brain-barrier 2026-03-25T02:02:24-04:00 0.7 https://www.rnaiscience.com/givosiran-cyp-enzyme-interactions 2026-03-25T02:02:24-04:00 0.7 https://www.rnaiscience.com/lumasiran-stability-prepared-syringe 2026-03-25T02:02:24-04:00 0.7 https://www.rnaiscience.com/vutrisiran-vitamin-levels 2026-03-25T02:02:24-04:00 0.7 https://www.rnaiscience.com/vutrisiran-injection-site-reactions 2026-03-25T02:05:22-04:00 0.7 https://www.rnaiscience.com/vutrisiran-pregnancy-lactation 2026-04-02T13:53:52-04:00 0.7 https://www.rnaiscience.com/vutrisiran-post-orthotopic-liver-transplant 2026-03-25T02:05:22-04:00 0.7 https://www.rnaiscience.com/vutrisiran-storage-and-stability 2026-03-25T02:05:22-04:00 0.7 https://www.rnaiscience.com/vutrisiran-switch-ttr-stabilizers-tafamidis-acoramidis-or-diflunisal 2026-03-25T02:05:22-04:00 0.7 https://www.rnaiscience.com/vutrisiran-helios-b-study 2026-03-25T02:05:22-04:00 0.7 https://www.rnaiscience.com/lumasiran-illuminate-c-study-overview 2026-03-25T02:05:22-04:00 0.7 https://www.rnaiscience.com/givosiran-post-dose-monitoring 2026-03-31T17:32:09-04:00 0.7 https://www.rnaiscience.com/vutrisiran-transitioning-antisense-oligonucleotide 2026-03-25T02:05:22-04:00 0.7 https://www.rnaiscience.com/vutrisiran-pharmacokinetic-and-pharmacodynamic-properties 2026-03-25T02:05:22-04:00 0.7 https://www.rnaiscience.com/patisiran-rwe-hattr-amyloidosis 2026-03-25T02:31:01-04:00 0.7 https://www.rnaiscience.com/vutrisiran-cardiac-results-helios-study 2026-04-02T12:57:13-04:00 0.7 https://www.rnaiscience.com/patisiran-cardiac-results-global-ole-study 2026-03-25T02:31:01-04:00 0.7 https://www.rnaiscience.com/patisiran-temperature-excursions 2026-03-25T02:31:01-04:00 0.7 https://www.rnaiscience.com/vutrisiran-helios-study 2026-03-25T02:31:01-04:00 0.7 https://www.rnaiscience.com/lumasiran-temperature-cycling-and-stability 2026-03-25T02:31:01-04:00 0.7 https://www.rnaiscience.com/givosiran-monthly-dosing-timeframe 2026-04-02T12:08:01-04:00 0.7 https://www.rnaiscience.com/lumasiran-illuminate-b-study-overview 2026-03-25T19:43:00-04:00 0.7 https://www.rnaiscience.com/patisiran-post-orthotopic-liver-transplant 2026-03-25T02:31:01-04:00 0.7 https://www.rnaiscience.com/patisiran-total-dilution-volume 2026-03-31T16:32:01-04:00 0.7 https://www.rnaiscience.com/lumasiran-pregnancy-and-lactation 2026-03-25T02:31:01-04:00 0.7 https://www.rnaiscience.com/lumasiran-dosing-regimen 2026-03-25T19:43:00-04:00 0.7 https://www.rnaiscience.com/lumasiran-preparation-and-administration 2026-03-25T19:43:00-04:00 0.7 https://www.rnaiscience.com/lumasiran-mechanism-action 2026-03-25T03:31:34-04:00 0.7 https://www.rnaiscience.com/lumasiran-illuminate-study-overview 2026-03-25T03:31:34-04:00 0.7 https://www.rnaiscience.com/givosiran-envision-study-36-month-results 2026-03-25T03:31:34-04:00 0.7 https://www.rnaiscience.com/givosiran-temperature-excursions 2026-03-25T03:31:34-04:00 0.7 https://www.rnaiscience.com/patisiran-product-stability 2026-04-01T12:49:01-04:00 0.7 https://www.rnaiscience.com/vutrisiran-mechanism-action 2026-03-25T03:31:34-04:00 0.7 https://www.rnaiscience.com/givosiran-anaphylactic-reactions-and-hypersensitivity 2026-03-25T03:31:34-04:00 0.7 https://www.rnaiscience.com/givosiran-timing-dosing 2026-04-01T16:52:01-04:00 0.7 https://www.rnaiscience.com/givosiran-stability-prepared-syringe 2026-03-25T04:32:01-04:00 0.7 https://www.rnaiscience.com/patisiran-management-extravasation 2026-03-25T04:32:01-04:00 0.7 https://www.rnaiscience.com/givosiran-hepatic-effects 2026-03-31T17:32:09-04:00 0.7 https://www.rnaiscience.com/givosiran-renal-effects 2026-03-25T04:32:01-04:00 0.7 https://www.rnaiscience.com/givosiran-use-patients-prior-history-hemin-prophylaxis 2026-03-25T04:32:01-04:00 0.7 https://www.rnaiscience.com/givosiran-pregnancy-and-lactation 2026-03-25T17:38:07-04:00 0.7 https://www.rnaiscience.com/givosiran-injection-site-reactions 2026-03-25T04:32:01-04:00 0.7 https://www.rnaiscience.com/patisiran-compatibility-commonly-used-infusion-components 2026-03-26T12:52:34-04:00 0.7 https://www.rnaiscience.com/givosiran-phase-12-open-label-extension 2026-03-25T04:32:01-04:00 0.7 https://www.rnaiscience.com/patisiran-vitamin-levels 2026-04-01T18:53:38-04:00 0.7 https://www.rnaiscience.com/givosiran-mechanism-action-and-chemical-properties 2026-03-31T17:32:09-04:00 0.7 https://www.rnaiscience.com/patisiran-hospitalization-and-mortality 2026-03-25T05:32:42-04:00 0.7 https://www.rnaiscience.com/patisiran-patients-heart-transplant 2026-03-25T05:32:42-04:00 0.7 https://www.rnaiscience.com/patisiran-premedications 2026-03-25T05:32:42-04:00 0.7 https://www.rnaiscience.com/patisiran-mechanism-action 2026-03-26T12:52:34-04:00 0.7 https://www.rnaiscience.com/patisiran-blood-brain-barrier 2026-03-25T05:32:42-04:00 0.7 https://www.rnaiscience.com/patisiran-filters-preparation-and-infusion 2026-03-25T05:32:42-04:00 0.7 https://www.rnaiscience.com/patisiran-apollo-study-results 2026-03-25T05:32:42-04:00 0.7 https://www.rnaiscience.com/patisiran-infusion-related-reactions 2026-03-25T05:32:42-04:00 0.7 https://www.rnaiscience.com/patisiran-preparation-and-administration 2026-03-25T05:32:42-04:00 0.7 https://www.rnaiscience.com/patisiran-pregnancy-and-lactation 2026-03-26T16:52:12-04:00 0.7 https://www.rnaiscience.com/patisiran-use-patients-renal-impairment 2026-03-25T06:28:18-04:00 0.7 https://www.rnaiscience.com/risk-seizures-among-patients-cerebral-amyloid-angiopathy-nationwide-retrospective-cohort-study 2026-03-25T08:34:00-04:00 0.7 https://www.rnaiscience.com/na 2026-03-27T11:10:05-04:00 0.7